 BOTHELL, Wash., March 1, 2022 PRNewswire -- BioLife Solutions, Inc. Nasdaq: BLFS BioLife or the Company, a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies CGT and the broader biopharma markets, today announced Mike Rice, Chairman and CEO, Rod de Greef, President and COO, and Troy Wichterman, CFO, are scheduled to present at both the Cowen and KeyBanc Investor Conferences in March 2022. 